New York 2025-2026 Regular Session

New York Senate Bill S05299

Introduced
2/20/25  

Caption

Requires prescription containers for opioid medications to have a red cap top and a printed warning about the risks of overdose and addiction.

Companion Bills

No companion bills found.

Previously Filed As

NY S06111

Requires prescription containers for opioid medications to have a red cap top and a printed warning about the risks of overdose and addiction.

NY A07010

Requires prescription containers for opioid medications to have a red cap top and a printed warning about the risks of overdose and addiction.

NY A09841

Requires practitioners to provide counselling to patients about the potential addictive properties of opioids prior to prescribing such medications; requires pharmacists to provide counselling to patients about the potential addictive properties of opioids at the time a prescription for opioids is filled.

NY A01227

Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications; requires that for the first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose.

NY S03521

Requires health practitioners to discuss with patients the risks associated with certain pain medications before prescribing such medications; requires that for the first opioid analgesic prescription of a calendar year the prescribing physician shall counsel the patient on the risks of overdose.

NY A01022

Requires prescription bottles containing opioids to have a label affixed concerning the addictive nature of the drug.

NY A00084

Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.

NY S08694

Requires prescription drug containers be labeled with a description of the size, shape, color and imprint of the prescription drug it contains.

NY A00770

Relates to patient counseling before issuing a prescription for a schedule II opioid; requires practitioners to consult with the patient regarding the quantity of the opioid and the patient's option to fill the prescription in a lesser quantity, and to inform the patient of the risks associated with opiate addiction and document the reason for the prescription.

NY S04870

Relates to patient counseling before issuing a prescription for a schedule II opioid; requires practitioners to consult with the patient regarding the quantity of the opioid and the patient's option to fill the prescription in a lesser quantity, and to inform the patient of the risks associated with opiate addiction and document the reason for the prescription.

Similar Bills

No similar bills found.